SHH and depressive symptom measurement: Deregulation of the Shh signal pathway leads to the occurrence of a wide range of neurological diseases, including autism, depression, dementia, stroke, Parkinson’s disease, Huntington’s disease, motor disorders, epilepsy, demyelinating disease, neuropathy and brain tumors [33].